Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Arch Therapeutics, Inc. | Financial_Report.xls |
| EX-31.2 - EXHIBIT 31.2 - Arch Therapeutics, Inc. | v395943_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Arch Therapeutics, Inc. | v395943_ex31-1.htm |
| EX-32.1 - EXHIBIT 32.1 - Arch Therapeutics, Inc. | v395943_ex32-1.htm |
| EX-3.1 - EXHIBIT 3.1 - Arch Therapeutics, Inc. | v395943_ex3-1.htm |
| 10-K - 10-K - Arch Therapeutics, Inc. | v395943_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
Arch Therapeutics, Inc. and Subsidiary
Wellesley, MA
We hereby consent to the incorporation by reference in the Registration Statement (No. 333-194745) on Form S-1 and the Registration Statement (No. 333-193516) on Form S-8 of our report dated December 12, 2014, relating to the consolidated financial statements of Arch Therapeutics, Inc. and subsidiary, as of and for the years ending September 30, 2014 and 2013.
We also consent to the reference to us under the heading “Experts” in such Registration Statements.
/s/ Moody, Famiglietti & Andronico, LLP
Tewksbury, Massachusetts
December 12, 2014